신경재활 기기 시장 - 예측(2026-2031년)

The neurorehabilitation devices market, with a 12.07% CAGR, is expected to grow to USD 3.679 billion in 2031 from USD 1.857 billion in 2025.

The neurorehabilitation devices market is experiencing steady expansion, driven by the urgent clinical need to improve functional recovery and quality of life for individuals suffering from neurological conditions and injuries. This growth is underpinned by several enduring demographic and technological trends, positioning the market as a critical component of modern neurological care and functional restoration.

Fundamental Market Drivers and Growth Catalysts

The market's foundation is supported by powerful, non-cyclical drivers. The global ageing population is a primary factor, as advanced age correlates strongly with a higher incidence of neurological disorders such as stroke, Parkinson's disease, Alzheimer's, and age-related cognitive decline. This demographic shift creates sustained demand for technologies that aid in cognitive training, motor function recovery, and the maintenance of independence.

Concurrently, the ongoing expansion and specialization of healthcare infrastructure, particularly the establishment of dedicated rehabilitation facilities, fuel market growth. These centers require a diverse array of advanced equipment to deliver comprehensive care, presenting continuous opportunities for device adoption and integration into clinical pathways.

Technological innovation remains the most dynamic growth vector. The market is characterized by the integration of sophisticated technologies including robotics, brain-computer interfaces (BCIs), non-invasive neurostimulation, and wearable sensors. These devices are moving beyond supportive roles to become active facilitators of targeted, repetitive, and data-informed therapy. A particularly significant trend is the integration of artificial intelligence (AI) and data analytics into these platforms. AI algorithms can analyze patient performance data to personalize therapy protocols in real-time, optimize rehabilitation strategies, and provide clinicians with actionable insights, thereby enhancing treatment efficacy and efficiency towards precision rehabilitation goals.

Market Segmentation and Competitive Landscape

The market is segmented by device type, application, end-user, and geography. Key device categories include neurorobotic systems (exoskeletons and rehabilitation robots), brain-computer interfaces, wearable devices for monitoring and stimulation, non-invasive stimulators (e.g., Transcranial Magnetic Stimulation), and neurorehabilitation gaming systems. End-users span hospitals, outpatient clinics, specialized rehabilitation centers, and an increasingly important home-care setting, which emphasizes the need for devices that are portable, user-friendly, and suitable for remote monitoring.

The competitive landscape features a mix of large, diversified medical technology corporations and specialized innovators. Major players like Abbott Laboratories leverage their expertise in neuromodulation, offering implantable and external neurostimulation devices for chronic pain and mobility disorders. Specialized companies such as Bioness Inc. focus on wearable functional electrical stimulation (FES) systems for limb rehabilitation, while pioneers like Ekso Bionics Holdings, Inc. lead in robotic exoskeleton technology for gait training and motor recovery. These key players hold significant market share through continuous innovation, strategic partnerships, and deep clinical validation of their technologies, contributing to a dynamic and competitive industry environment.

Geographical Outlook: North American Leadership

North America maintains a dominant position in the global neurorehabilitation devices market. This leadership is attributed to a confluence of factors: a well-established and advanced healthcare infrastructure that supports both clinical adoption and research & development; a high prevalence of neurological conditions within a sizable ageing population; and a regulatory and reimbursement environment that, while complex, has historically supported the integration of innovative medical technologies. Furthermore, the region is home to many leading market players and academic research centers, fostering a robust ecosystem for technological advancement and commercialization.

Future Trajectory and Strategic Importance

The market is poised for continued growth, propelled by the irreversible demographic trends of population ageing and the rising burden of chronic neurological disorders. The ongoing convergence of robotics, AI, sensor technology, and neuroscience is expected to yield a new generation of smarter, more adaptive, and more accessible rehabilitation tools. These advancements will further blur the lines between clinical and home-based care, enabling longer-term, data-driven therapy regimens.

Future success for industry participants will hinge on demonstrating not only technical sophistication but also clear clinical utility, cost-effectiveness, and improved patient outcomes. Devices that seamlessly integrate into clinical workflows, provide quantifiable progress metrics, and support the shift towards value-based care models will be particularly well-positioned. As the focus on long-term functional recovery and quality of life intensifies, neurorehabilitation devices will play an increasingly indispensable role in the continuum of neurological care, transforming rehabilitation from a supportive service into a central, technology-enabled therapeutic pillar.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Neurorehabilitation Devices Market Segmentation

• By Type
• Neurorobotic Systems
• Brain-Computer Interfaces
• Wearable Devices
• Non-Invasive Stimulators
• Neurorehabilitation Gaming Systems
• Others
• By Application
• Stroke
• Spinal Cord Injury
• Traumatic Brain Injury
• Parkinson's Disease
• Cerebral Palsy
• Others
• By End-User
• Hospitals
• Clinics
• Rehabilitation Centers
• Home Care Settings
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. NEUROREHABILITATION DEVICES MARKET BY TYPE

• 5.1. Introduction
• 5.2. Neurorobotic Systems
• 5.3. Brain-Computer Interfaces
• 5.4. Wearable Devices
• 5.5. Non-Invasive Stimulators
• 5.6. Neurorehabilitation Gaming Systems
• 5.7. Others

6. NEUROREHABILITATION DEVICES MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Stroke
• 6.3. Spinal Cord Injury
• 6.4. Traumatic Brain Injury
• 6.5. Parkinson's Disease
• 6.6. Cerebral Palsy
• 6.7. Others

7. NEUROREHABILITATION DEVICES MARKET BY END-USER

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Clinics
• 7.4. Rehabilitation Centers
• 7.5. Home Care Settings

8. NEUROREHABILITATION DEVICES MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Medtronic plc
• 10.2. Abbott Laboratories
• 10.3. Ekso Bionics Holdings, Inc.
• 10.4. Bionik Laboratories Corp.
• 10.5. St. Jude Medical (a subsidiary of Abbott Laboratories)
• 10.6. Hocoma AG (a subsidiary of DIH International Limited)
• 10.7. ReWalk Robotics Ltd.
• 10.8. Tyromotion GmbH
• 10.9. Kinova Robotics
• 10.10. Reha-Stim Medtec GmbH & Co. KG

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations